We revealed that in contrast to YY1 which could induce tumorigenesis, YY2 is a novel tumor suppressor which binds to the promoter region of tumor suppressor p53, promotes its transcriptional activity, activates the p53/p21 axis, and subsequently, suppresses cell cycle progression and cell proliferation. The gene discussed is CDKN1A; the disease is neoplasm.